Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Clin Cancer Res. 2012 Jul 26;18(19):5489–5498. doi: 10.1158/1078-0432.CCR-12-0507

Figure 1.

Figure 1

Dose normalized mean plasma concentration-time profiles of (A) dasatinib and (B) paclitaxel. The plasma concentrations for dasatinib (dasatinib alone (solid circles)) were lower after co-administration of paclitaxel (open circles) (A). Compared to paclitaxel alone treatment (solid circles and solid triangles), paclitaxel administered with dasatinib (open circles) showed comparable exposure to paclitaxel and 6-OH paclitaxel (combination with dasatinib (open triangles)) (B).